Skip to main content
. 2019 Apr 22;14(4):e0215547. doi: 10.1371/journal.pone.0215547

Fig 16. Relative administration cost for varying B2.

Fig 16

Relative glucose administration (A) cost per infusion and (B) total cost, and relative drug administration (C) cost per infusion and (D) total cost incurred for a period of 168h (7d) for concomitant and alternating controls with increasing B2.